112 Real-World Outcomes in Patients treated with First-line Anti-PD(L)-1 Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer - A Single Tertiary Centre Experience.
Saved in:
| Title: | 112 Real-World Outcomes in Patients treated with First-line Anti-PD(L)-1 Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer - A Single Tertiary Centre Experience. |
|---|---|
| Authors: | Radhika, Patel1 (AUTHOR), Akashi, Alam1 (AUTHOR), Tanith, Westerman1 (AUTHOR), Salina, Lalwani1 (AUTHOR), Adam, Januszewski1 (AUTHOR), Alfred, So1 (AUTHOR) |
| Source: | Lung Cancer (01695002). 2025 Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01695002 |
|---|---|
| DOI: | 10.1016/j.lungcan.2025.108222 |
